Release Date: Mar 2019
CC: MK, PBL, SBP
Octavia M. Peck Palmer, PhD
Medical Director, University of Pittsburgh Medical Center, Pittsburgh, PA; Associate Professor of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA
After completing this course, participants will be able to:
- Define sepsis and describe how it is a public health dilemma.
- Describe the sepsis-specific governmental and state policies and mandates that exist to detect and treat septic patients.
- Appraise published clinical data generated in critically ill patients and determine how to apply the Sepsis-3 guidelines to their patient population.
Who should attend? Practicing Pathologists, Residents, Doctoral Scientists, Pathologists’ Assistants, Laboratory Managers, Bench Supervisors, Bench Technologists & Technicians
This webcast course will provide participants with the epidemiology of sepsis and provide an overview of sepsis and how it differs from systemic inflammatory response syndrome (SIRS) and other infections and the epidemiology. The course will: 1) highlight the surviving sepsis campaign and policies (both governmental and state-specific) available to help healthcare providers identify and treat sepsis; 2) review diagnostics biomarkers (both old and new) that have been implicated in detecting sepsis and appraise data that either supports or denies use (clinical trials); and 3) assess patient outcomes (published state reports/hospital-based statistics) and their association to the policies and diagnostic biomarkers currently available. As a result of participating in the course, the learners will know how they can play an active role in identifying sepsis and reducing sepsis-associated mortality.